At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Sep 9, 2026 at 17:04 ET
Two Ascendis Pharma insiders sold a combined $873K in shares over a 7-day window, with the bulk ($811K) coming from SVP Mads Bodenhoff's open-market sale following a derivative exercise. Director Lars Holtug sold a small $62K stake. At a $17.7B market cap, the total sales represent ~0.005% of market cap, well below the 0.1% materiality threshold, making this a routine, non-informative cluster. The derivative exercise and same-day sale by Bodenhoff is a classic cashless exercise pattern, not a bearish signal.
- Two insiders sold shares totaling $873K (0.005% of $17.7B market cap)
- SVP Mads Bodenhoff exercised 3,000 options at $110, then sold the same shares at $270.19 for $811K, a routine cashless exercise
- Director Lars Holtug sold 236 shares for $62K, a trivial position reduction
- No C-suite executives (CEO/CFO) participated in the cluster
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access